超声介入瘤内注射无水酒精治疗原发性肝癌近期复发危险因素

doi:10.11904/j.issn.1002-3070.2015.03.006

实用肿瘤学杂志 ›› 2015, Vol. 29 ›› Issue (3): 216-220.doi: 10.11904/j.issn.1002-3070.2015.03.006

超声介入瘤内注射无水酒精治疗原发性肝癌近期复发危险因素

秦艳娟, 丁婷

湖北省孝感市中心医院超声科(孝感 432100)

收稿日期:2015-01-08 出版日期:2015-06-28 发布日期:2015-06-25
通讯作者: 丁婷 E-mail:1963027139@qq.com
作者简介:秦艳娟,女,(1979-),本科,主治医师,从事腹部超声的研究

The recurrent risk factors of ethanol injection by interventional ultrasound on treatment of primary liver cancer

QIN Yanjuan,DING Ting

Department of Ultrasonography,The Central Hospital of Xiaogan,Xiaogan 432100,China

Received:2015-01-08 Online:2015-06-28 Published:2015-06-25

摘要/Abstract

摘要：

目的探讨超声介入瘤内注射无水酒精治疗原发性肝癌后近期复发的危险因素。方法前瞻性收集我院2007年1月—2011年12月73例超声介入瘤内注射无水酒精治疗原发性肝癌患者的临床资料,利用单因素回归分析超声介入瘤内注射无水酒精治疗原发性肝癌的相关因素,然后用多元回归分析法对相关因素进行分析,确定其近期复发危险因素。结果单因素分析发现:患者的性别、年龄、血清乙肝HBsAg阳性阴性、肿瘤部位、肿瘤数目组间的生存率差异无统计学意义。肿瘤大小、血清AFP水平、有无门脉癌栓形成、肝功能(Child)分级、肿瘤分化程度、肿瘤不同转移部位之间生存率差异有统计学差异。经多因素分析及逐步回归结果显示,肝功能(Child)分级、肿瘤分化程度、肿瘤转移、门脉癌栓是预后显著相关的因素(卡方检验,χ²=47.763,P＜0.01;似然比检验,χ²=450.546,P＜0.01)。结论肝功能(Child)分级、肿瘤分化程度、肿瘤转移和门脉癌栓是超声介入后近期复发的危险因素。

关键词: 原发性肝癌, 无水酒精瘤内注射, 超声介入, 危险因素

Abstract:

Objective To find related risk factors after PEIT under ultrasound.Methods We collected the data of 73 clinical PEIT cases from January 2007 to December 2011.Univariate analysis found the related risk factors of PEIT.Multivariate analysis identified the independent risk factors.Results Single factor analysis showed that the differences between groups of patient′s sex,age,the positive and negative of serum HBsAg,tumor location,tumor number in survival rates were not statistically significant;the differences in groups of tumor size,serum AFP levels,with or without portal vein tumor thrombus,liver function(Child)grade,tumor type in survival rates were significant differences.Multivariate and stepwise regression analysis showed that liver function(Child)grade,tumor type,tumor metastasis,portal vein thrombosis were factors relevant to prognosis;all chi-square test,χ²=47.763,P＜0.01;likelihood ratio test χ²=450.546,P＜0.01.Conclusion liver function(Child-pugh grade),pathological type of tumors,tumor′s metastasis,emboli in portal vein are the risk factors after PEIT.

Key words: Primary liver cancer, Percutaneous ethanol injection therphy, Ultrasonic intervention, Risk factor

中图分类号:

R735.7

秦艳娟, 丁婷. 超声介入瘤内注射无水酒精治疗原发性肝癌近期复发危险因素[J]. 实用肿瘤学杂志, 2015, 29(3): 216-220.

QIN Yanjuan,DING Ting. The recurrent risk factors of ethanol injection by interventional ultrasound on treatment of primary liver cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 216-220.

参考文献

1 Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-201.
2 王法,王宏辉.肝动脉化疗栓塞术联合射频消融术治疗小肝癌的研究进展[J].实用肿瘤学杂志,2013,27(5):447-451.
3 Chen X,Liu HP,Li M,et al.Advances in non-surgical management of primary liver cancer[J].World J Gastroenterol,2014,20(44):16630-16638.
4 Bosetti C,Turati F,La Vecchia C.Hepatocellular carcinoma epidemiology[J].Best Pract Res Clin Gastroenterol,2014,28(5):753-770.
5 Khan KN,Yatsuhashi H,Yamasaki K,et al.Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection[J].J Hepatol,2000,32(2):269-278.
6 Savastano S,Miotto D,Casarrubea G,et,a1.Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child′s grade A or grade B cirrhosis:a multivariate analysis of prognosis factors[J].J Clin Gastroenterol,1999,28(4):334-340.
7 Kurokochi K,Watannabe S,Masaki T,et al.Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation radiofrequency ablation alone for patients with hepatocellular carcinoma[J].World J Gastrogenterol,2005,11(10):1426-1432.
8 Yin XY,Lu MD.Percutaneous ablation for small hepatocellular carcinoma[J].Expert Rev Gastroenterol Hepatol,2009,3(2):121-130.
9 麦聪,唐云强,洪剑,等.原发性肝癌术后早期复发相关因素研究[J].临床合理用药,2012,6(5):26-29.
10 Lau WY,Leung TW,Yu SC,et al.Percutaneous local ablative therapy for hepatocellular carcinoma:a review and look into the future[J].Ann Surg,2003,237(2):171-179.
11 Yamaoto K,Masuzawa M,Kato M,et al.Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization[J].Cancer Chemother Pharmacol,1992,31(suppl):77-81.
12 Yamashita Y,Bekki Y,Imai D,et al.Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer[J].Thromb Res,2014,134(4):826-831.
13 Zhou L,Rui JA,Wang SB,et al.Risk factors of microvascular invasion,portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma[J].Hepatogastroenterology,2014,61(134):1696-1703.
14 Park HJ,Kim K,Chie EK,et al.Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery[J].Anticancer Res,2014,34(11):6685-6690.
15 Zhang L,Liu FY,Fu JX,et al.Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model[J].Int J Clin Exp Pathol,2014,7(11):7775-7781.

[1]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[2]	贺伟, 母齐鸣, 王刚, 万波, 廖波, 杨娟. TACC3和p53蛋白在原发性肝癌组织中的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 420-425.
[3]	万静萱, 李红红, 周湘乡, 马琳. Ⅳ期肺癌合并肺血栓栓塞的危险因素分析[J]. 实用肿瘤学杂志, 2018, 32(3): 214-244.
[4]	倪成香,闻静,初幸之,许禅,翟建军. 39例原发性输卵管癌临床病理分析[J]. 实用肿瘤学杂志, 2017, 31(4): 335-341.
[5]	张丽霞，潘双花，何英平. 原发性肝癌患者心电图与转氨酶和电解质的相关性研究[J]. 实用肿瘤学杂志, 2016, 30(6): 523-526.
[6]	廖先珍, 颜仕鹏, 石菊芳, 石朝晖, 邹艳花, 肖海帆, 许可葵, 朱松林. 城市女性乳腺癌高危评估及筛查结果分析[J]. 实用肿瘤学杂志, 2016, 30(3): 245-248.
[7]	曲文书,华海清. 原发性肝癌骨转移55例预后分析[J]. 实用肿瘤学杂志, 2015, 29(4): 327-332.
[8]	刘春勋, 孙建民, 张玉宝, 赵红伟. 肝癌微波治疗术对患者肾功能影响因素的分析[J]. 实用肿瘤学杂志, 2015, 29(3): 212-215.
[9]	刘家综述, 刘瑞宝校审. 超米兰标准原发性肝癌TACE治疗的研究进展[J]. 实用肿瘤学杂志, 2015, 29(3): 279-283.
[10]	孔洁羽, 李胜棉. 原发性肝癌TACE术中常用抗肿瘤药物的疗效评价[J]. 实用肿瘤学杂志, 2015, 29(1): 82-85.
[11]	张新宇,王乐综述,张清媛审校. 三阴性乳腺癌易患因素的研究进展[J]. 实用肿瘤学杂志, 2014, 28(5): 477-480.
[12]	张建锋, 武雪亮, 王贵英, 周超熙, 牛文博, 席金川. 结肠癌D3清扫术后乳糜漏的危险因素分析[J]. 实用肿瘤学杂志, 2013, 27(4): 323-327.
[13]	高岩,姚文庆,王硕. 沈阳市子宫颈癌发病危险因素的病例对照研究[J]. 实用肿瘤学杂志, 2013, 27(2): 130-132.
[14]	刘佳综述, 白玉贤审校. 晚期原发性肝癌的全身化疗及靶向治疗现状[J]. 实用肿瘤学杂志, 2013, 27(1): 88-92.
[15]	阎素红, 赵长宏孙立春. 青年女性肺癌危险因素及临床特征分析[J]. 实用肿瘤学杂志, 2011, 25(2): 179-182.

超声介入瘤内注射无水酒精治疗原发性肝癌近期复发危险因素

The recurrent risk factors of ethanol injection by interventional ultrasound on treatment of primary liver cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价